BlackRock, Inc. 13D and 13G filings for Harpoon Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-07-08 4:56 pm Sale | 2022-06-30 | 13G | Harpoon Therapeutics, Inc. HARP | BlackRock Inc. BLK | 94,048 2.800% | -77,386 (-45.14%) | Filing |
| 2022-02-04 4:12 pm Purchase | 2021-12-31 | 13G | Harpoon Therapeutics, Inc. HARP | BlackRock Inc. BLK | 171,433 5.200% | 31,903 (+22.86%) | Filing |
| 2021-02-10 3:04 pm Purchase | 2021-01-31 | 13G | Harpoon Therapeutics, Inc. HARP | BlackRock Inc. BLK | 139,531 4.400% | 3,109 (+2.28%) | Filing |
| 2021-02-02 3:13 pm Purchase | 2020-12-31 | 13G | Harpoon Therapeutics, Inc. HARP | BlackRock Inc. BLK | 136,421 5.400% | 136,421 (New Position) | Filing |